Ovarian Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Ovarian Cancer, including details on symptoms, causes, treatment, information.

Volume 2 (2005), Issue 12 (December)

1. Loss of TNF-alpha-regulated COX-2 expression in ovarian cancer cells.
   Oncogene, 24(54): 7991-8002. [Abstract] [Full-text]
2. Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first-line treatment in patients with ovarian cancer. A multicenter phase II trial.
   Oncology, 69(4): 348-53. [Abstract] [Full-text]
3. Expression of VDR and CYP24A1 mRNA in human tumors.
   Cancer Chemother Pharmacol, 57(2): 234-40. [Abstract] [Full-text]
4. Tea consumption and ovarian cancer risk in a population-based cohort.
   Arch Intern Med, 165(22): 2683-6. [Abstract] [Full-text]
5. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
   Cancer, 104(12): 2807-16. [Abstract] [Full-text]
6. Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis.
   Hum Reprod Update, 12(1): 77-89. [Abstract] [Full-text]
7. Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression.
   Oncogene, 24(56): 8343-8. [Abstract] [Full-text]
8. Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells.
   Clin Cancer Res, 11(24): 8829-36. [Abstract] [Full-text]
9. Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer.
   Clin Cancer Res, 11(24): 8637-43. [Abstract] [Full-text]
10. Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.
    Clin Cancer Res, 11(24): 8585-91. [Abstract] [Full-text]
11. Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity.
    Proc Natl Acad Sci U S A, 102(51): 18269-74. [Abstract] [Full-text]
12. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.
    Proc Natl Acad Sci U S A, 102(51): 18538-43. [Abstract] [Full-text]
13. Silent event-related fMRI reveals deficient motor and enhanced somatosensory activation in orofacial dystonia.
    Brain, 129: 36-46. [Abstract] [Full-text]
14. TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer.
    Biochem Biophys Res Commun, 340(1): 256-62. [Abstract] [Full-text]
15. Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis.
    Int J Cancer, 118(5): 1325-9. [Abstract] [Full-text]
16. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
    Int J Cancer, 118(5): 1215-26. [Abstract] [Full-text]

© 2004-2008 Ovarian Cancer Research Today. All Rights Reserved.